SCIENTURE HOLDINGS, INC. Increase (Decrease) in Contract with Customer, Liability
SCIENTURE HOLDINGS, INC. (SCNX) reported Increase (Decrease) in Contract with Customer, Liability of $996 for the 3-month period ending 2022-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2023-05-15
- SCIENTURE HOLDINGS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2022-03-31 was $996.00.
- SCIENTURE HOLDINGS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2021-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2021-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2020-06-30 was -$302.40K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in contract with customer, liability for fiscal 2021 was -$10.00K, a 200.00% decline from fiscal 2020.
- SCIENTURE HOLDINGS, INC. increase (decrease) in contract with customer, liability for fiscal 2020 was $10.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2022-03-31 | $996.00 10-Q · filed 2023-05-15 | $996.00 derived: sum of 2 quarters · filed 2023-05-15 | $996.00 derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $0.00 derived: sum of 2 quarters · filed 2023-03-27 | -$10.00K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$10.00K 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | -$10.00K 10-Q · filed 2021-07-26 | |||
| 2020-12-31 | $10.00K 10-K · filed 2022-03-28 | |||
| 2020-06-30 | -$302.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-26 | $3.57K 10-Q · filed 2021-07-26 | ||
| 2020-03-31 | $305.97K 10-Q · filed 2021-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |